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Abstract
Background: Endothelial damage and angiogenesis are essential for atherosclerotic plaque development and
destabilization. We sought to examine whether contrast enhanced cardiovascular magnetic resonance (CMR) using
gadofosveset could show endothelial damage and neovessel formation in balloon injured porcine coronary
arteries.
Methods and Results: Data were obtained from seven pigs that all underwent balloon injury of the left anterior
descending coronary artery (LAD) to induce endothelial damage and angiogenesis. Between one - 12 days
(average four) after balloon injury, in vivo and ex vivo T1-weighted coronary CMR was performed after intravenous
injection of gadofosveset. Post contrast, CMR showed contrast enhancement of the coronary arteries with a
selective and time-dependent average expansion of the injured LAD segment area of 45% (p = 0.04; CI95 = [15%-
75%]), indicating local extravasation of gadofosveset. Vascular and perivascular extravasation of albumin (marker of
endothelial leakiness) and gadofosveset was demonstrated with agreement between Evans blue staining and ex
vivo CMR contrast enhancement (p = 0.026). Coronary MRI contrast enhancement and local microvessel density
determined by microscopic examination correlated (r = 0.82, p < 0.001).
Conclusion: Contrast enhanced coronary CMR with gadofosveset can detect experimentally induced endothelial
damage and angiogenesis in the porcine coronary artery wall.
Introduction
Atherosclerotic plaque rupture and erosion is by far the
most frequent cause of coronary thrombosis leading to
myocardial infarction or sudden coronary death.
Endothelial damage and angiogenesis are considered
essential for atherosclerotic plaque development and
destabilization [1-3]. Traditional X-ray coronary angio-
graphy is the clinical gold standard for diagnosing the
presence and extent of coronary artery disease (CAD),
but this technique is invasive and visualizes only the ves-
sel lumen and not the plaque composition. For this rea-
son, development of a non-invasive imaging technique to
identify endothelial damage and angiogenesis in the cor-
onary artery wall would have clinical implications.
Cardiovascular Magnetic Resonance (CMR) is a non-
invasive imaging technique that has emerged as one of
the most promising imaging modalities for assessing
atherosclerosis in larger arteries [4-8]. However, detec-
tion of plaque components in the coronary arteries
remains challenging due to respiratory and cardiac
motion combined with the need for high spatial resolu-
tion. Therefore, CMR contrast agents that improve
detection and characterization of coronary atherosclero-
tic plaques are needed.
Gadofosveset (Ablavar, Lanteus Medical Imaging, MA,
USA) is a gadolinium based blood pool contrast agent
used for magnetic resonance angiography [9]. It binds
reversibly to albumin and is predominantly present
within the vessel lumen but may enter the artery wall to
a greater degree through the leaky microvessels or the
damaged endothelium of atherosclerotic plaques [10,11].
Previous studies have shown that vulnerable plaque
features, such as endothelial damage, angiogenesis, and
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arteries by balloon inflation resulting in overstretching
[12]. For the purpose of inducing an overstretch injury
to model such plaque vulnerability features, balloon
injury was applied to the left anterior descending coron-
ary artery (LAD) of ten female Danish Land Race pigs.
We sought to determine whether contrast enhanced
CMR with gadofosveset could detect damaged endothe-
lium and microvessels in the injured coronary artery.
Methods
Animal Protocol
Ten female Danish Land Race pigs weighing 40 kg were
used for the experiments (Figure 1). All pigs were trea-
ted according to the Danish law on animal experiments.
The pigs were pre-sedated with an intramuscular injec-
tion of stressnill (1 ml/kg) and midazolam (1 ml/kg).
After induction of anesthesia with intravenous propofol
(5 mg/kg) and endotracheal intubation, anesthesia was
maintained with continuous intravenous infusion of pro-
pofol (8-10 mg/kg/hr) and fentanyl (2 mg/kg/hr). The
pigs were mechanically ventilated with a tidal volume of
450 ml (respiratory rate 12/min).
The right common femoral artery was exposed by a
surgical cut down, and a 9 F introducer sheath was
inserted into the artery followed by a bolus injection of
100 IU/kg heparin administrated through the sheat. A 4.5
mm over the wire angioplasty balloon was placed in the
LAD distal to the first diagonal branch. The coronary
lesion was induced by two inflations at 12 atmospheres
each lasting 30 seconds and with 60 seconds between the
inflations.
Acetylsalicylic acid (100 mg/d) was given orally after
the procedure and continued until euthanasia was
induced by phenobarbital. All pigs underwent CMR fol-
lowed by euthanasia between one and 12 days after the
balloon injury depending on scanner availability and
access to the animal laboratory.
Contrast Agent
Gadofosveset trisodium is a stable gadolinium diethyle-
netriaminepentaacetic acid (Gd-DTPA) chelate deriva-
tive with a diphenylcyclohexylphosphate group; the
molecular weight is 975.88 Da. It is applied as a small
molecule blood-pool contrast agent. Depending on
plasma concentration, 80% to 96% of gadofosveset is
reversibly bound to human serum albumin. The binding
to albumin sequesters most of the drug in the vascular
space, yielding a distribution half-life of 46 min ± 11
and a fivefold increase in r1relaxation (~20-23 mM
-1s
-1)
compared to non binding fraction of gadofosveset (~6
mM
-1s
-1) [13]. All animals received a standard dose of
gadofosveset (0.03 mmol/kg) administered intravenously
and followed by saline flush [10].
In vivo CMR
CMR was performed on a 1.5T MR system (Intera, Phi-
lips Medical Systems, Best, The Netherlands) using a
five element cardiac synergy coil. After a survey scan to
localize the heart and diaphragm, a multi-heart phase
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Figure 1 Study design, showing the time course of the in vivo CMR experiment. Balloon overstretch injury was induced in the LAD of 40
kg Danish Land Race pigs (n = 7). Post injury, gadofosveset enhanced coronary CMR was acquired. The animals were euthanized and ex vivo
CMR observations were correlated with histopathological findings. The number of animals assessed by CMR at different time points after the
balloon injury is indicated in parenthesis.
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tition time (TR) 2.6 ms; echo time (TE) 1.3 ms; flip
angle 60°; 50 heart phases; SENSE factor 2) was
obtained to assess the interval of minimal LAD motion
to determine the optimal trig g e rd e l a yf o rt h es u b s e -
quent coronary scans.
First, a coronary non-contrast enhanced bright blood
CMR angiography was performed with a previously
described navigator-gated, free-breathing and cardiac-
triggered T2 prepared 3D SSFP sequence allowing for
the visualization of the anatomy of the coronary artery
lumen (TR 4.9 ms; TE 2.5 ms; flip angle 90°) [14].
The contrast-enhanced coronary scan was a navigator-
gated, free-breathing and cardiac-triggered T1-weighted
inversion-recovery and fat-suppressed 3D SSFP
sequence (TR 4.9 ms; TE 2.5 ms; flip angle 90°). Spatial
resolution of both coronary scans was 1.3 × 1.3 × 3.0
mm
3 interpolated to 0.6 × 0.6 × 1.5 mm
3. The contrast-
enhanced coronary scan was performed once before
contrast injection. After the intravenous administration
of gadofosveset (0.3 mmol/kg), the scan was repeated
every five minutes until the signal intensity from the
coronary arteries had declined to a level that precluded
the quantitative analysis.
The inversion time (TI) of the inversion recovery
sequences was individually assessed before each acquisi-
tion according to the T1 of the myocardium using a TI
scout (Look Locker sequence). Typically, the inversion
time before contrast administration was 450-480 ms and
after contrast application 300-325 ms.
Ex vivo CMR
To document extravasation of contrast at the site of cor-
onary injury, ex-vivo high resolution imaging was per-
formed on the LAD in all pigs. The excised hearts were
drained for blood and placed inside the same MRI scan-
ner used for the in vivo imaging. A 47 mm circular
micro-coil was applied over the LAD. After initial survey
scans to locate the LAD, a high resolution IR 2D fast spin
echo scan was performed (echo train length 8; TR 1000
m s ;T E2 0m s ;f i e l do fv i e w( F O V )4×4c m ;m a t r i x2 5 6
× 256; slice thickness 1.5 mm). A fat saturation pulse was
used to eliminate the epicardial fat signal and thus
enhance the definition of the outer boundary of the ves-
sel. The inplane resolution obtained was 0.15 × 0.15 mm.
Histopathology
After injection, practically all Evans blue binds to albu-
min and as a result only enters the vessel wall and peri-
vascular area if there is a defect endothelial barrier
[15-17]. In this study, the dye was used to ease the locali-
zation of the balloon-injured LAD segment and to
macroscopically confirm that the balloon injury had
caused increased vessel wall permeability. The solution
was prepared by dissolving 2 g of Evans blue (Serva, Hei-
delberg, Germany) in 50 ml of isotonic saline. Evans blue
was administered through an ear vein cannula and
allowed to circulate in the bloodstream for 1 hr after
which the pigs were killed and the hearts were harvested.
After ex vivo CMR, the LAD was removed from the heart
and cut into 4 mm consecutive cross sectional slices and
subsequently photographed with a digital camera (Nikon,
Tokyo, Japan) for the purpose of registering any uptake
of Evans blue. Surrounding epicardial fat and myocar-
dium were included in the section for arterial support
during fixation and to improve matching with CMR
through the use of anatomical markers. All LAD slices
were fixated in formaldehyde and embedded in paraffin.
Four micron thick sections were cut and processed for
microscopic examination, including hematoxylin-eosin
(H&E) and immunohistochemistry for angiogenesis (von
Willebrand factor positive microvessels).
Data analysis
In vivo CMR
To assess extravasation of gadofosveset into the coron-
ary artery wall and perivascular area, the 3D coronary
data set was reformatted along the entire visualized
course of the coronaries [18].
The balloon-injured area of the LAD was located
visually by its relation to anatomical landmarks, such as
side branches identified on both x-ray and CMR angio-
grams. The average areas of the LAD and circumflex
artery were defined by manual tracing of the outer wall
boundary on the reformatted images by two observers
(SFP, ST) using the free software Osirix (version 2.5.7,
Geneva, Switzerland). An increase in the vessel area
over time was considered to reflect extravasation of con-
trast agent into the vessel wall and perivascular area.
Ex vivo CMR
Arterial lumen and outer wall boundary were manually
defined on each cross sectional CMR images using ImageJ
software (National Institutes of Health) by one observer
(SFP). A region of interest (ROI) was placed in a homoge-
neous region of the myocardium and the relative mean
signal intensity (SI) was calculated as: SIvessel/SImyocardium.
The balloon-injured (n = 7) and uninjured (n = 7) seg-
ments were scanned using multiple cross-sections per seg-
ment. If one or more of the CMR cross-sections were
positive for enhancement, the entire segment was classi-
fied as enhanced. Positive CMR enhancement was defined
as areas with SI 5 SD above the adjacent myocardium.
Histopathology
One observer (SFP) reviewed all histopathology.
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Cross-sectional slices were prepared from both the balloon-
injured and uninjured segments. Photos of the cross sec-
tional sliced LAD segments were inspected and based on
t h ep r e s e n c eo ra b s e n c eo fa ni n t e n s eb l u ec o l o ri nt h ev e s -
sel wall and perivascular area that was visually distinct from
the surrounding tissue, each cross-section was categorized
as being either positive or negative for Evans blue uptake. If
one or more of the cross-sections contained Evans blue, the
entire balloon-injured (n = 7) and uninjured (n = 7) seg-
ments were classified as Evans blue positive.
Balloon injury
The H&E-stained sections from each balloon injured
LAD segment were studied microscopically to determine
if the balloon inflations had caused overstretch injury to
the artery wall, defined as a total disconnection of the
tunica media.
Microvessel
To evaluate the microvessel density, the adventitia of
interest was manually defined on the histological sec-
tions stained for von Willebrand factor using ImageJ
software (National Institutes of Health). The microvessel
density was calculated as follows:
Microvessels/mm
2 = Number of microvessels/vessel
wall and adjacent adventitia area (mm
2)
The average microvessel density was calculated for
uninjured vs injured segments, respectively, and the
results were compared.
Ex vivo CMR versus Evans blue and Microvessels
Ex vivo CMR images were matched with the corre-
sponding photos (Evans blue) and histological sections
(microvessels) by using landmarks such as the relative
distance from the left coronary ostium and gross mor-
phological features such as the overall shape and size of
the lumen and vessel wall.
The agreement between the occurrences of vessel wall
enhancement on T1 weighted CMR images and Evans
blue (endothelial leakiness) was determined by registering
all matches and mismatches between the two variables.
The average relative SI of the balloon injured and unin-
jured segments were calculated and compared. Finally,
the relative SI of the balloon injured and uninjured seg-
ments were correlated to the average microvessel density
measured on the corresponding histological slices.
Statistical Analysis
The post-contrast increase in vessel area of the LAD
and circumflex artery was tested by the signed Wilcoxon
rank sum test. The association between gadofosveset
enhancement of the vessel wall and uptake of Evans
blue was tested with a 2-tailed Fischer’se x a c tt e s t .T h e
average microvessel density and the relative CMR signal
intensity for the balloon-injured and uninjured segments
were compared, using a Wilcoxon signed rank test. The
correlation between coronary vessel wall SI by CMR and
microvessel density was investigated using Spearman
correlation test. The interobserver and intraobserver
variability were assessed by a 1-way random, 1-measure
intraclass correlation coefficient (ICC). The statistical
analysis was performed using SPSS software version 18.0
(SPSS Inc. Chicago, IL).
Results
Ten pigs were subjected to the experimental protocol,
three of the pigs died of ventricular fibrillation during
the balloon intervention leaving seven pigs for further
investigation. All in and ex vivo CMR examinations of
the remaining pigs were successfully performed.
In vivo CMR
The non contrast enhanced coronary angiograms did
not show any visual signs of injury to the LAD. Twenty
minutes post gadofosveset injection, suboptimal image
quality caused by tachycardia necessitated the exclusion
of two of the pigs. Thus, five of the pigs have data for
the full length of observation (60 minutes).
T h eg a d o f o s v e s e te n h a n c e da n g i o g r a m ss h o w e da
selective and time-dependent expansion of the injured
LAD segment area until 30 minutes after the adminis-
tration of gadofosveset after which it reached a plateau
(Figure 2 and 3). Thirty minutes post contrast, CMR of
the injured LAD segment demonstrated contrast
enhancement of the vessel yielding a significant increase
in the average artery area of 45% (p = 0.04; CI95=[ 1 5 % -
75%]) while the average area of the uninjured circumflex
artery (CX) and uninjured part of the LAD artery
remained constant with an average increase of 7% (p =
0.8; [1%-12%]) and 11% (p = 0.08; [-6%-27%]), respec-
tively. Using a cut-off-value of 10% relative area
increase, we found both the sensitivity and specificity to
be 100% at thirty minutes post contrast.
Histopathology
Evans blue
A total of sixty-five LAD cross sections were photo-
graphed for the purpose of documenting up-take of
Evans blue into the vessel wall. Five of these photos
were excluded due to insufficient image quality and
additional 10 photos were excluded due to non-success-
ful matching to the corresponding ex vivo CMR leaving
50 cross-sectional photos for further investigation (aver-
age seven photos pr pig). In the seven balloon-injured
segments, a total of thirty cross-sections were obtained.
For the seven uninjured segments, 20 cross-sections
were obtained. Based on the photo observations, 32
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tive, with 27 (84%) originating from balloon-injured seg-
ments. Eighteen cross-sections were classified as being
negative for Evans blue uptake, with 15 (83%) originat-
ing from uninjured cross-sections.
Balloon injury
The LAD segments that were exposed to balloon over-
stretch all displayed ruptured tunica media, i.e., total
disconnection of the tunica media, on the H&E stained
histological sections, indicating balloon injury.
Microvessels
Sixty-five histological sections were immunohistochemi-
cally stained for von Willebrand factor. The histological
sections could be matched with the ex vivo CMR images
in 30 cases (average four pr pig). The difference in aver-
age microvessel density between the balloon injured and
uninjured segments was 7.6 vessel/mm
2 (p = 0.075).
Ex-vivo CMR
On average, the balloon injured segments were 34% more
enhanced than the uninjured segments (p = 0.043).
Figure 2 Coronary bright-blood CMR-angiography (A). T1-weighted inversion recovery at 5 min (B) 15 min (C), and 25 min (D) following
intravenous administration of gadofosveset. The area of the balloon injured LAD2 segment expands over time indicating time-dependent
extravasation of contrast, whereas the intact LAD1 segment (arrow) and CX (dotted arrow) remain constant.
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Figure 3 Expansion of the contrast enhanced vessel area (CX, LAD1, and injured LAD2) as a function of time for all pigs (dotted lines)
and average (bold lines). Thirty minutes post contrast, the injured LAD2 segment showed an average expansion of 45% (p = 0.04) while the
average area of the uninjured CX and LAD1 artery remained constant with an average expansion of 7% (p = 0.8) and 11% (p = 0.08),
respectively. In two pigs, images obtained 20 minutes post injection of gadofosveset were excluded due to poor image quality.
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Gadofosveset contrast enhancement of the injured arter-
ial wall was documented by ex vivo CMR. We detected
enhancement in 24 out of 32 Evans blue positive cross
sections and in 1 out of 18 Evans blue negative cross
sections. There was a significant association between
segments showing positive coronary artery wall
enhancement and segments showing Evans blue uptake
(p = 0.026) (Table 1 and Figure 4). There was a signifi-
cant correlation between the average SI of the LAD seg-
ments and average segment microvessel density
(Spearman’s r = 0.82, p < 0.001) (Figure 5).
Interobserver and intraobserver agreement
Interobserver and intraobserver agreement for the assess-
ment of in vivo coronary vessel areas were 0.94 (p <
0.001) CI95 = [0.92 - 0.97]) and 0.95 (p < 0.001) CI95 =
[0.94- 0.97], respectively.
Discussion
We have demonstrated that CMR in combination with
gadofosveset, an intravascular contrast agent with a high
affinity to albumin, enables in vivo differentiation between
injured and normal porcine coronary artery walls. In addi-
tion, we have shown that the contrast enhancement of the
coronary artery wall was in good agreement with endothe-
lial damage assessed by Evans blue and correlated with
microvessel density measured on corresponding arterial
sections with immunohistochemistry.
We detected contrast enhancement in 24 of 32 (75%)
injured coronary cross sections while enhancement
occurred in only one out of 18 (6%) uninjured coronary
cross sections. The most likely mechanism is that albu-
min enters the injured lesions through damaged or miss-
ing endothelium and leaky microvessels [10,19]. Since
80% of gadofosveset will be bound to serum albumin, it
will extravasate into the injured artery wall together with
albumin. In addition, unbound extracellular gadofosveset
may also bind directly to lesion resident albumin in the
artery wall. This observation is consistent with observa-
tions by Kooi et al. who recently described that gadofos-
veset showed specific signal enhancement in the artery
wall of atherosclerotic rabbits containing an increased
number of microvessels, whereas only limited enhance-
ment was seen in normal vessels [10]. Due to the gradual
uptake of gadofosveset into the injured coronary vessel
wall, the optimal time for combined lumen and vessel
wall imaging would be approximately 30 minutes after
contrast injection. The relative area increase of the proxi-
mal uninjured LAD segment appeared greater than in the
uninjured CX segment indicating that the proximal LAD
segment was injured in some cases, which was confirmed
by the detection of Evans blue in 5 (25%) out of the
20 uninjured cross sectional LAD slices. The unintended
injuries to the proximal LAD most likely occurred doing
the withdrawal of the balloon causing denudation of the
endothelium.
One of the pigs was imaged at day one after the bal-
loon injury, which is too early for neovessels to develop
in the lesion area. Despite the lack of neovessels, the
diameter of the vessel still increased, indicating that
endothelial damage alone can cause extravasation of
gadofosveset into the vessel wall. Consequently, we were
unable to discriminate between endothelial damage and
neovessels.
Previous approaches for imaging of atherosclerotic
plaque
Low molecular weight gadolinium chelates, like
Gd-DTPA (gadopentetatedimeglumine), has been used to
improve atherosclerotic plaque detection [5,20-23]. One
major limitation for low molecular contrast agents is that
these small molecular weight probes are known to diffuse
quickly from the blood into the extracellular space and
enters both the normal and atherosclerotic vessel walls
[10]. The differentiation between stable and vulnerable
plaques using Gd-DTPA and delayed enhancement CMR
is therefore difficult. This is reflected in patient studies
where enhancement of coronary plaques has been
observed both in patients with stable angina and in
patients with acute coronary syndromes [24,25]. Dynamic
contrast enhanced CMR combined with pharmacokinetic
analysis of Gd-DTPA uptake has been shown to correlate
with microvessel density in human carotid plaques [26],
but due to cardiac motion this approach is challenging
for the coronary arteries.
Recently, other gadolinium based contrast agents such
as Gadoflurine and B-22956/1 (Gadocoletic acid triso-
diumsalt) have been shown to enhance specific compo-
nents associated with advanced atherosclerotic plaques
in atherosclerotic rabbits [27,28]. These contrast agents
could potentially be used for atherosclerotic plaque
detection in the future.
Vulnerable plaque imaging can also be performed
using ultra small super paramagnetic iron oxide
(USPIO) particles, which enables detection of
Table 1 Correlation between Evans blue and MR
enhancement
Evans Blue: + Evans Blue: - Total
MR Enhancement: + 80 8
MR Enhancement: - 24 6
Total 10 4 14
Observed agreement of CMR enhancement and Evans blue uptake calculated
for both injured and uninjured segments. Positive CMR enhancement was
defined as areas with SI 5 SD above the adjacent myocardium and Evans blue
was defined as an intense blue color in the vessel wall and perivascular area
that was visually distinct from the surrounding tissue. (+) = Yes (-) = No.
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tic rabbits and human carotid arteries [29,30]. After
phagocytosis by macrophages, USPIO can be detected
through susceptibility effects using T2* weighted CMR
sequences. However, to our knowledge, this has never
been demonstrated in the coronary arteries and since
the best imaging time point after injection of USPIO is
reported to be around 36 hours, the clinical use may be
limited.
Limitations
In this study, we demonstrated that mechanically
induced endothelial damage and angiogenesis could be
visualized using Gadofosveset. Although endothelial
damage and angiogenesis are features of advanced ather-
osclerotic plaques, other vulnerable plaque components
are missing such as a lipid-rich necrotic core with a
fibrous cap. Validation in animal models with athero-
sclerosis is warranted before judging the applicability of
the method for assessing advanced human plaques.
Matching the ex vivo CMR to histology is challenging
and associated with a certain level of inaccuracy despite
careful matching, given the large disparity in slice thick-
ness (4 μm for histology and 1.5 mm for CMR).
Conclusion
The contrast agent gadofosveset allowed for non-invasive
detection of endothelial damage and angiogenesis in bal-
loon injured porcine coronary arteries. Therefore, gado-
fosveset enhanced CMR has a potential to identify
vulnerable atherosclerotic plaques in human coronary
arteries.
Figure 4 Ex vivo T1-weighted CMR images of a balloon injured porcine coronary artery after injection of gadofosveset (A). Photo of
the corresponding segment demonstrating extravasation of Evans blue into the arterial wall (B). Histological identification of microvessels
(positive for von Willebrand factor). Note the strong CMR signal located at the coronary artery wall after injection of gadofosveset corresponding
to the area with uptake of Evans blue and to microvessel-rich areas in the histological section (C+D).
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